Kiniksa Provides Update on U.S. FDA Review of Investigational New Drug Application for Mavrilimumab in Giant Cell Arteritis

World News: . []

HAMILTON Bermuda Dec 06 2018 GLOBE NEWSWIRE) -- Nasdaq KNSA Kiniksa a biopharmaceutical company with a pipeline consisting of five product candidates across various stages of development focused on autoinflammatory and autoimmun e condi...

More news and information about Kiniksa Pharmaceuticals, Ltd.

Published By:

Globe Newswire: 13:00 GMT Thursday 6th December 2018

Published: .

Search for other references to "kiniksa" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us